Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy: Phase 3 Study

NCT05597280 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.

NCT NCT05597280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05597280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy: Phase 3 Study
Lead sponsor
Institute of Tropical Medicine, Belgium
Phase
Phase 3
Overall status
Recruiting
Start date
March 22, 2023
Completion date
March 15, 2027
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leprosy